Post-IPO Debt - Cytosorbents
Investment Firm
Overview
Cytosorbents develops therapeutic devices used in purifying blood to treat life-threatening diseases.
Announced Date
Jul 01, 2016
Funding Type
Post Ipo Debt
Highlights
Location
United States, North America
Social
Participant Investors
1
| Investor Name |
|---|
Round Details and Background
Cytosorbents raised $10000000 on 2016-07-01 in Post-IPO Debt
Cytosorbents develops therapeutic devices used in purifying blood to treat life-threatening diseases.
Company Funding History
11
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jul 02, 2024 |  Post-IPO Debt - Cytosorbents | 1 | - | 15.0M |
| Jun 30, 2017 | Post-IPO Debt - Cytosorbents | 1 | - | 5.0M |
| Oct 11, 2013 | Post-IPO Debt - Cytosorbents | - | 745.0K | |
| Aug 08, 2013 | Post-IPO Debt - Cytosorbents | - | 1.1M |
Recent Activity
There is no recent news or activity for this profile.